바이러스학 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00006886
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 227
Buy Now

바이러스학 시장은 2021년 41억 827만 달러에서 2028년 52억 7648만 달러에 이를 것으로 예상됩니다. 2021년부터 2028년까지 3.6%의 CAGR을 기록할 것으로 예상됩니다.

바이러스학은 의료 시스템의 중요한 부분 중 하나입니다. 이는 백신 개발, 진단, 치료 요법 등에 광범위하게 적용됩니다.   바이러스학 시장 참가자들은 시장에서 경쟁을 유지하기 위해 제품 혁신과 개발에 지속적으로 참여하고 있습니다. 그들은 제품 혁신을 위한 다양한 범위를 탐구합니다. 예를 들어, 코로나19의 경우 시장 참여자들은 백신, 테스트 키트, 기타 관련 제품 및 서비스 개발에 상당한 투자를 하고 있습니다. 다음은 바이러스 시장과 관련된 시장 발전 중 일부입니다.
  • 2021년 8월 미국 식품의약국(FDA)은 다음과 같은 최초의 코로나19 백신을 승인했습니다. 화이자-바이오NTech 코로나19 백신. 이는 ComiRNAty(Koe-mir’-na-tee)라는 이름으로 판매될 예정입니다. 이 백신은 16세 이상 개인의 코로나19 질병을 예방하기 위한 것입니다. 긴급 사용 승인(EUA) 하에서도 사용할 수 있습니다.
  • 2021년 4월 CerTest Biotec은 BD MAX 시스템을 위한 CE 인증 코로나19 진단 테스트를 출시했습니다.
  • 5월 2020년 Bio-Rad는 코로나19 총 항체 테스트에 대한 긴급 사용 승인에 대한 FDA 승인을 받았습니다.
  • 2020년 5월 Aalto Bio Reagents는 새로운 재조합 진핵생물 SARS-CoV-2 S1-S2 스파이크 단백질을 출시했습니다.
따라서 제품 혁신과 다양한 국가의 정부 지원을 통한 시장 참여자의 적극적인 참여는 바이러스 시장의 성장을 뒷받침합니다.  바이러스학 시장의 수익성 있는 지역


 시장 통찰력성장 최소 침습적 및 비침습적 미용 시술의 채택으로 바이러스 시장 성장 촉진인간 면역결핍 바이러스(HIV), 독감 바이러스, 지카 바이러스, 에볼라 바이러스, SARS-CoV-2 및 소아마비 바이러스와 같은 바이러스가 대규모 감염 전 세계 인구. 바이러스가 지속적으로 돌연변이를 일으키고 진화함에 따라 약물 내성은 인간과 동물의 바이러스 감염 관리에 있어 주요 과제가 됩니다. 바이러스는 유형에 따라 다양한 매체를 통해 전송됩니다. 예를 들어, 일부 바이러스는 독감, 감기, 호흡기세포융합바이러스 감염 등 호흡기 바이러스 질환을 일으키며 기침이나 재채기를 통해 생성된 비말을 통해 전파되는 반면, 일부 위장관 바이러스 질환은 감염된 사람의 대변과의 직접적인 접촉을 통해 전파됩니다. 사람이나 오염된 음식이나 물을 통해. UNAIDS  글로벌 HIV & AIDS 통계에 따르면 2020년 전 세계적으로 3,770만 명이 넘는 사람들이 HIV에 감염되었습니다.

국제 바이러스 분류 위원회(ICTV)는 코로나19를 유발한 새로운 코로나바이러스를 선언했습니다. -19는 2020년 2월 중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2)로 명명되었습니다. 이 바이러스는 발병 이후 몇 차례 돌연변이를 겪었고, 이는 코로나19 대유행의 심각성을 더욱 가중시켰습니다. 예를 들어, 질병통제예방센터(CDC)의 코로나19 추적 데이터에 따르면 2021년 8월 현재 10만명당 7일 발병률은 299.4건이며, 미국에서는 164,952건이 넘는 새로운 사례가 보고되었습니다. 또한 유럽 질병 예방 통제 센터에 따르면 2021년 8월 현재 유럽 경제 지역(EEA)의 총 코로나19 사례 수는 약 36,307,572명에 달했습니다. 따라서 이러한 바이러스 감염의 확산은 바이러스학 시장의 성장을 주도하고 있습니다. 유형 기반 통찰력유형에 따라 바이러스학은 시장은 진단 테스트, 바이러스 감염 제어 기술, 항바이러스 치료제 및 인터페론으로 더욱 세분화됩니다. 2021년에는 진단 테스트 부문이 시장에서 가장 큰 점유율을 차지할 것으로 예상되며, 바이러스 감염 관리 기술 부문은 2021~2028년에 가장 높은 CAGR을 기록할 것으로 예상됩니다. < h2>제품별 바이러스 시장(2021년 및 2028년)

 애플리케이션 기반 통찰력애플리케이션 기반 , 시장은 피부 및 연조직 감염, 호흡기 감염, 위장관 감염, 성병, 요로 감염 등으로 분류됩니다. 2021년에는 호흡기 감염 부문이 시장에서 가장 큰 점유율을 차지할 것으로 예상되며, 2021~2028년에는 가장 높은 CAGR을 기록할 것으로 예상됩니다.

전략적 통찰력 바이러스학 시장에서 활동하는 기업은 전 세계적으로 진화하는 고객 요구를 충족하기 위해 제품 혁신 전략을 채택하는 것을 강조하며, 이를 통해 글로벌 시장에서 브랜드 이름을 유지할 수도 있습니다.  바이러스 시장 – 세분화 유형별
  • 진단 테스트
    • DNA 바이러스 테스트
    • RNA 바이러스 검사
    • 기타
  • 바이러스 감염 통제 기술
    • 능동적 예방
    • 수동적 예방
  • 항바이러스 치료제
    • 바이러스 치료제
    • 항바이러스제
    • 면역 조절제
  • 인터페론 
용도별
  • 피부 및 연조직 감염
  • 호흡기 감염
  • 위장 감염
  • 성병
  • 요로 감염
  • 기타
By 최종 사용자
  • 병원
  • 진단 실험실
  • 제약 및 생명공학 회사
  • 연구 및 학술 기관
지역별
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 프랑스
    • 독일
    • 이탈리아
    • 영국< /li>
    • 스페인
    • 유럽 나머지 지역
  • 아시아 태평양
    • 중국
    • 인도< /li>
    • 대한민국
    • 일본
    • 호주
    • 나머지 APAC
  • 중간 동부 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • UAE
    • 나머지 MEA
  • 남미 및 중미
    • 브라질
    • 아르헨티나
    • 나머지 SCAM
 회사 프로필
  • Abbott
  • Johnson & 존슨 서비스, Inc.
  • F. Hoffmann-LA Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Qiagen
  • < li>Illumina, Inc.
  • Siemens AG
  • GlaxoSmithKline Plc
  • < li>Gilead Sciences, Inc.
  • AbbVie, Inc.pyright 이름은 각 웹사이트에 명시되어 있습니다.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is Virology?

Virology is a detailed study of viruses that focuses on the structure, classification, evolution, and genetics of viruses. The virology market caters to the prevention and development of treatments for several viral diseases. The increasing prevalence of emerging infectious diseases (EIDs)—chikungunya, Ebola, West Nile virus, severe acute respiratory syndrome (SARS), and Lyme disease is driving the growth of the virology market. The key driving factors for the market growth are, rising prevalence of viral infections and other infectious diseases along with growing awareness about diagnosis and treatment of the disease.

What are the factors impacting for the virology market?

The factors that are driving and restraining factors that will affect virology market in the coming years. Factors such as rising prevalence of viral infectious diseases and increasing product launches, are driving the market growth. However, availability of alternative products and high cost of production of products are likely to hamper the growth of the market.

Who are the major players in the virology market?

The virology market majorly consists of the players such as Abbott, Johnson & Johnson Services, Inc., F. Hoffmann-LA Roche Ltd., Thermo Fisher Scientific, Inc., Qiagen, Illumina, Inc., Siemens AG, GlaxoSmithKline Plc, Gilead Sciences, Inc., and AbbVie, Inc. are amongst others.

What is the market value of virology market based on region?

The global virology market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America dominates the global virology market due to factors such as technological advancement, increasing product launches, and increasing investment in healthcare and research. The transmission of infectious diseases globally has made diagnosis mandatory for travelers. Today, the diseases are spreading faster around the world, which is further bolstering the demand for diagnostic tools as they can help control the outbreak at an early stage. For instance, in September 2019, the FDA approved OraQuick Ebola Rapid Antigen Test, a new rapid diagnostic test for Ebola in the US.

Asia Pacific is expected to be the fastest growing region Asia Pacific is expected to expand at a high growth rate due to large patient population, increasing government support to provide better healthcare services, and increasing product launches by market players. For instance, in 2018, Cepheid initiated the HBDC Access Program1 for the diagnosis of HIV, viral hepatitis (HCV), and human papillomavirus (HPV)2 at a relatively lower price. The company is aiming to make tests that would be more accessible to lower-income countries.

Which is the most influencing segment growing in the virology market report?

The global virology market based on based on type is segmented into diagnostic test, viral infection controlling techniques, antiviral therapeutics, and interferons. In 2021, Antiviral Therapeutics segment is estimated to account for the largest market share in the global virology market. the growth can be attributed to increasing prevalence of human immunodeficiency virus (HIV) and increasing research and development investment by private and public companies for antiviral drugs.

The List of Companies - Virology Market

  1. Abbott
  2. Johnson And Johnson Services, Inc.
  3. F. HOFFMANN-LA ROCHE LTD.
  4. THERMO FISHER SCIENTIFIC INC.
  5. QIAGEN
  6. Illumina, Inc.
  7. Siemens AG
  8. Glaxosmithkline Plc
  9. Abbvie Inc.
  10. Gilead Sciences, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports